📣 VC round data is live. Check it out!

Synthetic MR Valuation Multiples

Discover Synthetic MR's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like VSee Health, Pheton Holdings, AMA Corp, Genomed and more.

Synthetic MR Overview

About Synthetic MR

Synthetic MR AB develops software solutions for Magnetic Resonance Imaging that support shorter exam times and deliver more information to the clinician. Its product is available in different packages. SyMRI IMAGE provides high MRI workflows and enables automatic segmentation of brain tissue, providing objective decision support, MAGiC is a customer-specific version of SyMRI IMAGE marketed and sold by GE Healthcare under a license agreement, SyMRI NEURO includes contrast images, biomarker segmentation, volumetric measurements of brain tissues and quantitative parametric maps, and SyMRI Research Edition includes contrast images, volumetric measurements and quantitative maps to provide more information to the researcher.


Founded

2007

HQ

Sweden

Employees

40

Financials (LTM)

Revenue: $7M
EBITDA: ($2M)

EV

$5M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Synthetic MR Financials

Synthetic MR reported last 12-month revenue of $7M and negative EBITDA of ($2M).

In the same LTM period, Synthetic MR generated ($3M) in gross profit, ($2M) in EBITDA losses, and had net loss of ($4M).

Revenue (LTM)


Synthetic MR P&L

In the most recent fiscal year, Synthetic MR reported revenue of $6M and EBITDA of ($3M).

Synthetic MR is unprofitable as of last fiscal year, with gross margin of 109%, EBITDA margin of (49%), and net margin of (93%).

See analyst estimates for Synthetic MR
LTMLast FY202320242025202620272028
Revenue$7M$6M$10M$6M$6M
Gross Profit($3M)$7M$10M$7M$7M
Gross Margin(53%)109%106%111%112%
EBITDA($2M)($3M)$2M($960K)($5M)
EBITDA Margin(31%)(49%)22%(16%)(75%)
EBIT Margin(61%)(85%)16%(35%)(88%)
Net Profit($4M)($6M)$1M($2M)($6M)
Net Margin(67%)(93%)11%(29%)(96%)

Financial data powered by Morningstar, Inc.

Synthetic MR Stock Performance

Synthetic MR has current market cap of $8M, and enterprise value of $5M.

Market Cap Evolution


Synthetic MR's stock price is $0.09.

Synthetic MR share price increased by 1.3% in the last 30 days, and decreased by 73.6% in the last year.

Synthetic MR has an EPS (earnings per share) of $-0.07.

See more trading valuation data for Synthetic MR
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$5M$8M4.6%1.3%-1.5%-73.6%$-0.07

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Synthetic MR Valuation Multiples

Synthetic MR trades at 0.7x EV/Revenue multiple, and (2.4x) EV/EBITDA.

See NTM and 2027E valuation multiples for Synthetic MR

EV / Revenue (LTM)


Synthetic MR Financial Valuation Multiples

As of June 3, 2026, Synthetic MR has market cap of $8M and EV of $5M.

Synthetic MR has a P/E ratio of (1.9x).

LTMLast FY202320242025202620272028
EV/Revenue0.7x0.8x0.5x0.8x0.8x
EV/EBITDA(2.4x)(1.5x)2.3x(4.9x)(1.0x)
EV/EBIT(1.2x)(0.9x)3.1x(2.3x)(0.9x)
EV/Gross Profit(1.4x)0.7x0.5x0.7x0.7x
P/E(1.9x)(1.4x)7.7x(4.8x)(1.4x)
EV/FCF(2.8x)(3.3x)(2.7x)(4.2x)(3.3x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Synthetic MR Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Synthetic MR Margins & Growth Rates

Synthetic MR grew revenue by 8% but EBITDA decreased by 84% in the last fiscal year.

In the most recent fiscal year, Synthetic MR reported gross margin of 109%, EBITDA margin of (49%), and net margin of (93%).

See estimated margins and future growth rates for Synthetic MR

Synthetic MR Margins

Last FY202420252026202720282029
Gross Margin109%111%112%(21%)
EBITDA Margin(49%)(16%)(75%)(8%)
EBIT Margin(85%)(35%)(88%)(29%)
Net Margin(93%)(29%)(96%)(29%)
FCF Margin(23%)(19%)(23%)(30%)

Synthetic MR Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth8%(38%)2%11%
Gross Profit Growth(120%)(35%)4%(120%)
EBITDA Growth(84%)(146%)378%(89%)
EBIT Growth(64%)(239%)155%(64%)
Net Profit Growth(67%)(261%)242%(67%)
FCF Growth44%(37%)28%44%

Data powered by FactSet, Inc. and Morningstar, Inc.

Synthetic MR Operational KPIs

Synthetic MR's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.3M for the same period.

Synthetic MR's Rule of 40 is 4% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Synthetic MR's Rule of X is 20% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Synthetic MR
LTMLast FY202320242025202620272028
Rule of 40(18%)4%---
Bessemer Rule of X2%20%---
Revenue per Employee-$0.2M---
Opex per Employee-$0.3M---
Opex to Revenue-194%90%146%200%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Synthetic MR Competitors

Synthetic MR competitors include VSee Health, Pheton Holdings, AMA Corp, Genomed, Media Lab, Induct, Vidavo, NRGene, Kontigo Care and Brainscan.

Most Synthetic MR public comparables operate across Medical Imaging & Diagnostics, Healthcare Software, HealthTech, B2B SaaS, Vertical SaaS and Longevity.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
VSee Health0.6x-(1.0x)-
Pheton Holdings----
AMA Corp3.6x-(1.4x)-
Genomed0.9x-5.6x-
Media Lab4.1x-13.3x-
Induct4.0x-8.1x-
Vidavo3.9x-10.3x-
NRGene1.8x-(5.8x)-

This data is available for Pro users. Sign up to see all Synthetic MR competitors and their valuation data.

Start Free Trial

Acquisitions by Synthetic MR

Synthetic MR has acquired 1 company to date.

Last acquisition by Synthetic MR was on November 28th 2024. Synthetic MR acquired Combinostics for $5M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Synthetic MR

Combinostics
Description
Combinostics is a Tampere, Finland-based medical software company developing AI-assisted diagnostic tools for neurology. Its FDA-cleared cTAI platform analyzes brain CT scans to detect acute intracranial pathologies like stroke and hemorrhage, aiding radiologists in emergency settings across Europe and the US.
HQ CountryFinland
HQ City
Tampere
Deal Date28 Nov 2024
Valuation$5M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Synthetic MR acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Synthetic MR

When was Synthetic MR founded?Synthetic MR was founded in 2007.
Where is Synthetic MR headquartered?Synthetic MR is headquartered in Sweden.
How many employees does Synthetic MR have?As of today, Synthetic MR has over 40 employees.
Is Synthetic MR publicly listed?Yes, Synthetic MR is a public company listed on Nasdaq Stockholm.
What is the stock symbol of Synthetic MR?Synthetic MR trades under SYNT ticker.
When did Synthetic MR go public?Synthetic MR went public in 2013.
Who are competitors of Synthetic MR?Synthetic MR main competitors include VSee Health, Pheton Holdings, AMA Corp, Genomed, Media Lab, Induct, Vidavo, NRGene, Kontigo Care, Brainscan.
What is the current market cap of Synthetic MR?Synthetic MR's current market cap is $8M.
What is the current revenue of Synthetic MR?Synthetic MR's last 12 months revenue is $7M.
What is the current revenue growth of Synthetic MR?Synthetic MR revenue growth (NTM/LTM) is 13%.
What is the current EV/Revenue multiple of Synthetic MR?Current revenue multiple of Synthetic MR is 0.7x.
Is Synthetic MR profitable?No, Synthetic MR is not profitable.
What is the current EBITDA of Synthetic MR?Synthetic MR has negative EBITDA and is not profitable.
What is Synthetic MR's EBITDA margin?Synthetic MR's last 12 months EBITDA margin is (31%).
What is the current EV/EBITDA multiple of Synthetic MR?Current EBITDA multiple of Synthetic MR is (2.4x).
What is the current FCF of Synthetic MR?Synthetic MR's last 12 months FCF is ($2M).
What is Synthetic MR's FCF margin?Synthetic MR's last 12 months FCF margin is (26%).
What is the current EV/FCF multiple of Synthetic MR?Current FCF multiple of Synthetic MR is (2.8x).
How many companies Synthetic MR has acquired to date?As of June 2026, Synthetic MR has acquired 1 company.
What was the largest acquisition by Synthetic MR?$5M acquisition of Combinostics on 28th November 2024 was the largest M&A Synthetic MR has done to date.
What companies Synthetic MR acquired?Synthetic MR acquired Combinostics.
In how many companies Synthetic MR has invested to date?Synthetic MR hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Synthetic MR

Lists including Synthetic MR

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial